Nappi A,Berretta M,Romano C,Tafuto S,Cassata A,Casaretti R .2018 .Metastatic colorectal cancer: role of target therapies and future perspectives. Curr Cancer Drug Targets, 18(5) : 421-9.
Binnebosel M,Lambertz A,Dejong K,Neumann UP .2018 .Oligometastasized colorectal cancer-modern treatment strategies. Chirurg, 89(7) : 497-504.
McMillan DC,Wotherspoon HA,Fearon KC,Sturgeon C,Cooke TG,McArdle CS .1995 .A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg, 9610(99) : 6-7.
Mahar AL,Compton C,Halabi S,Hess KR,Weiser MR,Groome PA .2017 .Personalizing prognosis in colorectal cancer: A systematic review of the quality and nature of clinical prognostic tools for survival outcomes. J Surg Oncol, 116(8) : 969-82.
Campisi J .2013 .Aging, cellular senescence, and cancer. Annu Rev Physiol, 030 : 212-183653.
Gutschner T,Diederichs S. .2012 .The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol, 9(6) : 703-19.
Kopp F,Mendell JT .2018 .Functional classification and experimental dissection of long noncoding RNAs. Cell, 01(3) : 393-407.
Quinn JJ,Chang HY .2015 .Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet, 10(1) : 47-62.
Bhan A,Soleimani M .2017 .Mandal SS. Long noncoding Rna and cancer: A new paradigm. Cancer Res, 16(15) : 0008-5472.
Peng WX,Koirala P,Mo YY .2017 .LncRNA-mediated regulation of cell signaling in cancer. Oncogene, 184(41) : 5661-7.
Bartonicek N,Maag JL,Dinger ME .2016 .Long noncoding RNAs in cancer: mechanisms of action and technological advancements. Mol Cancer, 15(1) : 43.
Qiu MT,Hu JW,Yin R,Xu L .2013 .Long noncoding RNA: an emerging paradigm of cancer research. Tumour Biol, 34(2) : 613-20.
Xu S,Sui S,Zhang J,Bai N,Shi Q,Zhang G .2015 .Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer. Int J Clin Exp Pathol, 8(5) : 4881-91.
Ji Q,Liu X,Fu X,Zhang L,Sui H,Zhou L .2013 .: e78700. PLoS One, 8(11) : .
Bolha L,Ravnik-Glavac M .2017 .Glavac D. Long noncoding RNAs as biomarkers in cancer. Dis Markers, : 7243968.
Fattahi S,Kosari-Monfared M,Golpour M,Emami Z,Ghasemiyan M,Nouri M .2020 .LncRNAs as potential diagnostic and prognostic biomarkers in gastric cancer: A novel approach to personalized medicine. J Cell Physiol, 235(4) : 3189-206.
Dastmalchi N,Safaralizadeh R,Nargesi MM .2020 .LncRNAs: Potential novel prognostic and diagnostic biomarkers in colorectal cancer. Curr Med Chem, 27(30) : 5067-77.
Marmol I,Sanchez-de-Diego C,Pradilla Dieste A,Cerrada E .2017 .Colorectal carcinoma: a general overview and future perspectives in colorectal cancer. Int J Mol Sci, 18(1) : 197-202.
Li X,Cao Y,Gong X,Li H. .2017 .Long noncoding RNAs in head and neck cancer. Oncotarget, 8(6) : 10726-40.
Abbastabar M,Sarfi M,Golestani A,Khalili E. .2018 .lncRNA involvement in hepatocellular carcinoma metastasis and prognosis. EXCLI J, 17(3) : 1541-13.
Li C,Chen J,Zhang K,Feng B,Wang R .2015 .Progress and prospects of long noncoding RNAs (lncrnas) in hepatocellular carcinoma. Cell Physiol Biochem, 36(2) : 423-34.
Kulasingam V,Diamandis EP .2008 .Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Nat Clin Pract Oncol, 5(10) : 588-99.
Sun C,Yuan Q,Wu D,Meng X,Wang B .2017 .Identification of core genes and outcome in gastric cancer using bioinformatics analysis. Oncotarget, 8(41) : 70271-80.
Lian P,Wang Q,Zhao Y,Chen C,Sun X,Li H .2019 .An eight-long non-coding RNA signature as a candidate prognostic biomarker for bladder cancer. Aging (Albany NY), 11(17) : 6930-40.
Tang J,Ren J,Cui Q,Zhang D,Kong D,Liao X .2019 .A prognostic 10-lncRNA expression signature for predicting the risk of tumour recurrence in breast cancer patients. J Cell Mol Med, 23(10) : 6775-84.
Jiang W,Guo Q,Wang C,Zhu Y. .2019 .A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma. Cancer Cell Int, 19 : 208.
Miao R,Ge C,Zhang X,He Y,Ma X,Xiang X .2019 .Combined eight-long noncoding RNA signature: a new risk score predicting prognosis in elderly non-small cell lung cancer patients. Aging (Albany NY), 11(2) : 467-79.
Bray F,Ferlay J,Soerjomataram I,Siegel RL,Torre LA,Jemal A .2018 .GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 68(6) : 394-424.
Benson AB,Venook AP,Cederquist L,Chan E,Chen YJ,Cooper HS,NCCN HS .2017 .Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 15(3) : 370-98.
Kita Y,Yonemori K,Osako Y,Baba K,Mori S,Maemura K .2016 .Noncoding RNA and colorectal cancer: its epigenetic role. J Hum Genet, 66(1) : 41-7.
Weng M,Wu D,Yang C,Peng H,Wang G,Wang T .2016 .Noncoding RNAs in the development, diagnosis, and prognosis of colorectal cancer. Transl Res, 10(3) : 108-20.
Huang B,Chang C,Wang BL,Li H .2019 .-induced upregulation of lncRNA TRPM2-AS promotes tumor progression in gastric cancer by regulating miR-195/ HMGA1 axis. J Cell Biochem, 120(10) : 16921-33.
Lavorgna G,Chiacchiera F,Briganti A,Montorsi F,Pasini D,Salonia A .2014 .Expression-profiling of apoptosis induced by ablation of the long ncRNA TRPM2-AS in prostate cancer cell. Genom Data, 10 : 4-5.
Xu C,Huang Q,Zhang C,Xu W,Xu G,Zhao X .2018 .Long non-coding RNA TRPM2-AS as a potential biomarker for hepatocellular carcinoma. Ir J Med Sci, 187(3) : 621-8.
Fan X,Ashraf UM,Drummond CA,Shi H,Zhang X,Kumarasamy S .2018 .Characterization of a long non-coding RNA, the antisense RNA of Na/K-ATPase alpha1 in human kidney cells. Int J Mol Sci, 19(7) : .
Holst MR,Vidal-Quadras M,Larsson E,Song J,Hubert M,Blomberg J .2017 .Clathrin-independent endocytosis suppresses cancer cell blebbing and invasion. Cell Rep, 08(8) : 1893-905.
Kim DH,Wirtz D. .2013 .Focal adhesion size uniquely predicts cell migration. FASEB J, 27(4) : 220160-61.
Wei L,Yin F,Zhang W .2017 .: e6345. Medicine (Baltimore), 96(12) : .
Buhrmann C,Shayan P,Goel A,Shakibaei M. .2017 .Resveratrol regulates colorectal cancer cell invasion by modulation of focal adhesion molecules. Nutrients, 9(10) : 1073-7.
Burridge K. .2017 .Focal adhesions: a personal perspective on a half century of progress. FEBS J, 284(20) : 3355-61.
Li Y,Guo H,Jin C,Qiu C,Gao M,Zhang L .2017 .Spliceosome-associated factor CTNNBL1 promotes proliferation and invasion in ovarian cancer. Exp Cell Res, 05(1) : 124-34.
Hsu TY,Simon LM,Neill NJ,Marcotte R,Sayad A,Bland CS .2015 .The spliceosome is a therapeutic vulnerability in MYC-driven cancer. Nature, 525(7569) : 384-8.
Bonnal S,Vigevani L,Valcarcel J. .2012 .The spliceosome as a target of novel antitumour drugs. Nat Rev Drug Discov, 11(11) : 847-59.
Maury E,Hashizume R .2016 .Epigenetic modification in chromatin machinery and its deregulation in pediatric brain tumors: Insight into epigenetic therapies. Epigenetics, 1278(5) : 353-69.
Audia JE,Campbell RM .2016 .Histone modifications and cancer. Cold Spring Harb Perspect Biol, 8(4) : a019521-7.
Chi P,Allis CD,Wang GG .2010 .Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer, 10(7) : 457-69.
Janke C .2011 .Post-translational regulation of the microtubule cytoskeleton: mechanisms and functions. Nat Rev Mol Cell Biol, 12(12) : 773-86.